Schlagbauer Wadl H - Search Results

1

Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.

Okamoto I, Pirc-Danoewinata H, Ackermann J, Drach J, Schlagbauer Wadl H, Jansen B, Wolff K, Pehamberger H, Marosi C. Okamoto I, et al. Among authors: schlagbauer wadl h. Br J Cancer. 1999 Jan;79(1):131-7. doi: 10.1038/sj.bjc.6690022. Br J Cancer. 1999. PMID: 10408704 Free PMC article.

2

Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis.

Jansen B, Schlagbauer-Wadl H, Eichler HG, Wolff K, van Elsas A, Schrier PI, Pehamberger H. Jansen B, et al. Among authors: schlagbauer wadl h. Cancer Res. 1997 Feb 1;57(3):362-5. Cancer Res. 1997. PMID: 9012455

3

Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy.

Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP, Wolff K, Pehamberger H, Jansen B. Heere-Ress E, et al. Among authors: schlagbauer wadl h. Int J Cancer. 2002 May 1;99(1):29-34. doi: 10.1002/ijc.10248. Int J Cancer. 2002. PMID: 11948488

4

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.

Jansen B, Schlagbauer-Wadl H, Brown BD, Bryan RN, van Elsas A, Müller M, Wolff K, Eichler HG, Pehamberger H. Jansen B, et al. Among authors: schlagbauer wadl h. Nat Med. 1998 Feb;4(2):232-4. doi: 10.1038/nm0298-232. Nat Med. 1998. PMID: 9461199

5

Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines.

Selzer E, Schlagbauer-Wadl H, Okamoto I, Pehamberger H, Pötter R, Jansen B. Selzer E, et al. Among authors: schlagbauer wadl h. Melanoma Res. 1998 Jun;8(3):197-203. doi: 10.1097/00008390-199806000-00001. Melanoma Res. 1998. PMID: 9664140

6

Influence of increased c-Myc expression on the growth characteristics of human melanoma.

Schlagbauer-Wadl H, Griffioen M, van Elsas A, Schrier PI, Pustelnik T, Eichler HG, Wolff K, Pehamberger H, Jansen B. Schlagbauer-Wadl H, et al. J Invest Dermatol. 1999 Mar;112(3):332-6. doi: 10.1046/j.1523-1747.1999.00506.x. J Invest Dermatol. 1999. PMID: 10084311 Free article.

7

Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.

Schlagbauer-Wadl H, Jansen B, Müller M, Polterauer P, Wolff K, Eichler HG, Pehamberger H, Konak E, Johnson JP. Schlagbauer-Wadl H, et al. Int J Cancer. 1999 Jun 11;81(6):951-5. doi: 10.1002/(sici)1097-0215(19990611)81:6<951::aid-ijc18>3.0.co;2-v. Int J Cancer. 1999. PMID: 10362144

8

Novel Ras antagonist blocks human melanoma growth.

Jansen B, Schlagbauer-Wadl H, Kahr H, Heere-Ress E, Mayer BX, Eichler H, Pehamberger H, Gana-Weisz M, Ben-David E, Kloog Y, Wolff K. Jansen B, et al. Among authors: schlagbauer wadl h. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14019-24. doi: 10.1073/pnas.96.24.14019. Proc Natl Acad Sci U S A. 1999. PMID: 10570191 Free PMC article.

9

Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice.

Jansen B, Heere-Ress E, Schlagbauer-Wadl H, Halaschek-Wiener J, Waltering S, Moll I, Pehamberger H, Marciano D, Kloog Y, Wolff K. Jansen B, et al. Among authors: schlagbauer wadl h. J Mol Med (Berl). 1999 Nov;77(11):792-7. doi: 10.1007/s001099900052. J Mol Med (Berl). 1999. PMID: 10619439

10

A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.

Halaschek-Wiener J, Wacheck V, Schlagbauer-Wadl H, Wolff K, Kloog Y, Jansen B. Halaschek-Wiener J, et al. Among authors: schlagbauer wadl h. Mol Med. 2000 Aug;6(8):693-704. Mol Med. 2000. PMID: 11055588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters